Literature DB >> 12089076

Whooping cough--a continuing problem.

N S Crowcroft, Joseph Britto.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12089076      PMCID: PMC1123488          DOI: 10.1136/bmj.324.7353.1537

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  10 in total

1.  Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity.

Authors:  E Njamkepo; F Rimlinger; S Thiberge; Nicole Guiso
Journal:  Vaccine       Date:  2002-01-31       Impact factor: 3.641

2.  The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales.

Authors:  W John Edmunds; Marc Brisson; Alessia Melegaro; Nigel J Gay
Journal:  Vaccine       Date:  2002-01-31       Impact factor: 3.641

3.  Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland.

Authors:  A Gzyl; E Augustynowicz; I van Loo; J Slusarczyk
Journal:  Vaccine       Date:  2001-11-12       Impact factor: 3.641

4.  Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.

Authors:  N K Fry; S Neal; T G Harrison; E Miller; R Matthews; R C George
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

5.  Pertussis is increasing in unimmunized infants: is a change in policy needed?

Authors:  S Ranganathan; R Tasker; R Booy; P Habibi; S Nadel; J Britto
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

6.  The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998.

Authors:  W K Yih; S M Lett; F N des Vignes; K M Garrison; P L Sipe; C D Marchant
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

Review 7.  Reflections on the efficacy of pertussis vaccines.

Authors:  P E Fine; J A Clarkson
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

8.  The changing age and seasonal profile of pertussis in Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Diane MacDonald; Wrency Wu; Carol Shaw; Jane Macnabb; Sylvie Champagne; David M Patrick; Scott A Halperin
Journal:  J Infect Dis       Date:  2002-04-22       Impact factor: 5.226

9.  Pertussis is a frequent cause of prolonged cough illness in adults and adolescents.

Authors:  L D Senzilet; S A Halperin; J S Spika; M Alagaratnam; A Morris; B Smith
Journal:  Clin Infect Dis       Date:  2001-05-21       Impact factor: 9.079

10.  Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.

Authors:  F R Mooi; H van Oirschot; K Heuvelman; H G van der Heide; W Gaastra; R J Willems
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

  10 in total
  12 in total

1.  Surveillance of whooping cough should continue.

Authors:  Ruth C Matthews; Noel W Preston; Debbie J Holden
Journal:  BMJ       Date:  2002-10-19

2.  Is pertussis being considered as a cause of persistent cough among adults?

Authors:  Carine Couzigou; Antoine Flahault
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

3.  Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s.

Authors:  Leo M Schouls; Han G J van der Heide; Luc Vauterin; Paul Vauterin; Frits R Mooi
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

4.  Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada.

Authors:  Raymond S W Tsang; Allan K H Lau; Michelle L Sill; Scott A Halperin; Paul Van Caeseele; Frances Jamieson; Irene E Martin
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

5.  Whooping cough metapopulation dynamics in tropical conditions: disease persistence and impact of vaccination.

Authors:  Hélène Broutin; François Simondon; Jean-François Guégan
Journal:  Proc Biol Sci       Date:  2004-08-07       Impact factor: 5.349

6.  Characterization of serological responses to pertussis.

Authors:  Mineo Watanabe; Beverly Connelly; Alison A Weiss
Journal:  Clin Vaccine Immunol       Date:  2006-03

7.  Severe and unrecognised: pertussis in UK infants.

Authors:  N S Crowcroft; R Booy; T Harrison; L Spicer; J Britto; Q Mok; P Heath; I Murdoch; M Zambon; R George; E Miller
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

8.  Accelerating control of pertussis in England and Wales.

Authors:  Helen Campbell; Gayatri Amirthalingam; Nick Andrews; Norman K Fry; Robert C George; Timothy G Harrison; Elizabeth Miller
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

Review 9.  Perplexities of pertussis: recent global epidemiological trends and their potential causes.

Authors:  D W Jackson; Pejman Rohani
Journal:  Epidemiol Infect       Date:  2013-01-16       Impact factor: 4.434

10.  Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica.

Authors:  Dimitri A Diavatopoulos; Craig A Cummings; Leo M Schouls; Mary M Brinig; David A Relman; Frits R Mooi
Journal:  PLoS Pathog       Date:  2005-12-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.